The document defines electronic prescribing as the electronic transmission of prescription information between a prescriber, dispenser, pharmacy benefit manager, or health plan. It outlines some barriers to e-prescribing such as costs and potential impacts on workflow, as well as benefits like improved patient care and reduced healthcare costs. The document also discusses government incentives for e-prescribing and notes that an interim final rule now allows electronic prescriptions for controlled substances.